Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| OmniAb, Inc. | 4,403,277 | reported | 18 Feb 2026 | tx 87+12,289,532−1,062,939 |
| CONNETICS CORP | 0 | reported | 29 Dec 2006 | tx 21+56,794−92,959 |
| LIGAND PHARMACEUTICALS INC | 0 | reported | 01 Nov 2022 | tx 202+1,121,753−613,364 |
| RITTER PHARMACEUTICALS INC | 0 | reported | 10 Apr 2020 | tx 16+302,447−38,561 |
Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 13 buys in history.
| OmniAb, Inc. |
| 0 |
| reported |
| 01 Nov 2022 |
| tx 12+87,071−495,710 |
| Viking Therapeutics, Inc. | 0 | reported | 02 Jan 2026 | tx 27+434,172−85,786 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 18 Feb 2026 | EXERCISE | OmniAb, Inc. | 58,333 | — | |
| 18 Feb 2026 | SALE | OmniAb, Inc. | 30,843 | 1.71 USD | |
| 18 Feb 2026 | EXERCISE | OmniAb, Inc. | 58,333 | 0.00 USD | deriv |
| 18 Feb 2026 | GRANT_AWARD | OmniAb, Inc. | 156,250 | 0.00 USD | deriv |
| 18 Feb 2026 | GRANT_AWARD | OmniAb, Inc. | 1,562,500 | 0.00 USD | deriv |
| 16 Feb 2026 | EXERCISE | OmniAb, Inc. | 36,458 | 0.00 USD | |
| 17 Feb 2026 | SALE | OmniAb, Inc. | 20,754 | 1.70 USD | |
| 16 Feb 2026 | EXERCISE | OmniAb, Inc. | 36,458 | 0.00 USD | deriv |
| 02 Jan 2026 | GRANT_AWARD | Viking Therapeutics, Inc. | 3,150 | 0.00 USD | |
| 02 Jan 2026 | EXERCISE | Viking Therapeutics, Inc. | 16,000 | 3.33 USD | |
| 02 Jan 2026 | SALE | Viking Therapeutics, Inc. | 16,000 | 35.11 USD | |
| 02 Jan 2026 | EXERCISE | Viking Therapeutics, Inc. | 16,000 | 0.00 USD | deriv |
| 02 Jan 2026 | GRANT_AWARD | Viking Therapeutics, Inc. | 20,400 | 0.00 USD | deriv |
| 08 Dec 2025 | SALE | OmniAb, Inc. | 13,666 | 1.96 USD | |
| 07 Dec 2025 | EXERCISE | OmniAb, Inc. | 26,554 | 0.00 USD | |
| 07 Dec 2025 | EXERCISE | OmniAb, Inc. | 26,554 | 0.00 USD | deriv |
| 26 Aug 2025 | GRANT_AWARD | OmniAb, Inc. | 540,540 | 1.85 USD | |
| 11 Apr 2025 | EXERCISE | Viking Therapeutics, Inc. | 20,786 | 8.00 USD | |
| 11 Apr 2025 | EXERCISE | Viking Therapeutics, Inc. | 20,786 | 0.00 USD | deriv |
| 07 Apr 2025 | EXERCISE | OmniAb, Inc. | 36,458 | 0.00 USD | |
| 07 Apr 2025 | SALE | OmniAb, Inc. | 19,382 | 2.00 USD | |
| 07 Apr 2025 | EXERCISE | OmniAb, Inc. | 36,458 | 0.00 USD | deriv |
| 16 Feb 2025 | EXERCISE | OmniAb, Inc. | 36,458 | — | |
| 15 Feb 2025 | EXERCISE | OmniAb, Inc. | 26,549 | — | |
| 18 Feb 2025 | SALE | OmniAb, Inc. | 13,964 | 3.68 USD |
1 purchase reported after at least 12 months of silence — most recent on 10 Jun 2021.